HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).
Clinical trial NCT07517510 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07517510
- Sponsor
- Guangdong Second Provincial General Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2026-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.